Aims To establish the safety, tolerability and most promising regimen of darexaban (YM150),
a novel, oral, direct factor Xa inhibitor, for prevention of ischaemic events in acute coronary …

Background Storage symptoms are often undertreated in men with lower urinary tract symptoms
(LUTS). Objective To evaluate the combination of an antimuscarinic (solifenacin) with an …

In recent years, there has been an increase in knowledge of cancer, accompanied by a
technological development that gives rise to medical oncology. An instrument that allows the …

Background Diabetic kidney disease (DKD) remains one of the leading causes of
premature death in diabetes. DKD is classified on albuminuria and reduced kidney function (estimated …

Background Many patients with diabetic kidney disease have residual albuminuria and are
at risk of disease progression. The ALBUM trial investigated the efficacy of a novel, orally …

In clinical research subjects are usually observed during a period of time. Primary and
secondary endpoints are often either responses measured longitudinally over time or the time at …

Background Dapagliflozin is a sodium-glucose cotransporter-2 inhibitor approved for the
treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin as an …

With a treatment policy strategy, therapies are evaluated regardless of the disturbance caused
by intercurrent events (ICEs). Implementing this estimand is challenging if subjects are not …

Background Established cardiovascular risk assessment tools lack chronic kidney disease–specific
clinical factors and may underestimate cardiovascular risk in non–dialysis-…

Background Orthognathic surgery is the cornerstone of the treatment of dentofacial deformities,
which have a great psychological and social impact on the life of the patient. Patient …